153 related articles for article (PubMed ID: 29845423)
21. Association between small heat shock protein B11 and the prognostic value of MGMT promoter methylation in patients with high-grade glioma.
Cheng W; Li M; Jiang Y; Zhang C; Cai J; Wang K; Wu A
J Neurosurg; 2016 Jul; 125(1):7-16. PubMed ID: 26544773
[TBL] [Abstract][Full Text] [Related]
22. Glioma cell VEGFR-2 confers resistance to chemotherapeutic and antiangiogenic treatments in PTEN-deficient glioblastoma.
Kessler T; Sahm F; Blaes J; Osswald M; Rübmann P; Milford D; Urban S; Jestaedt L; Heiland S; Bendszus M; Hertenstein A; Pfenning PN; Ruiz de Almodóvar C; Wick A; Winkler F; von Deimling A; Platten M; Wick W; Weiler M
Oncotarget; 2015 Oct; 6(31):31050-68. PubMed ID: 25682871
[TBL] [Abstract][Full Text] [Related]
23. Hypericin uptake: a prognostic marker for survival in high-grade glioma.
Ritz R; Müller M; Dietz K; Duffner F; Bornemann A; Roser F; Tatagiba M
J Clin Neurosci; 2008 Jul; 15(7):778-83. PubMed ID: 18394904
[TBL] [Abstract][Full Text] [Related]
24. PI3 kinase mutations and mutational load as poor prognostic markers in diffuse glioma patients.
Draaisma K; Wijnenga MM; Weenink B; Gao Y; Smid M; Robe P; van den Bent MJ; French PJ
Acta Neuropathol Commun; 2015 Dec; 3():88. PubMed ID: 26699864
[TBL] [Abstract][Full Text] [Related]
25. Glucose-6-phosphate dehydrogenase deficiency and reduced haemoglobin levels in African children with severe malaria.
Nguetse CN; Meyer CG; Adegnika AA; Agbenyega T; Ogutu BR; Kremsner PG; Velavan TP
Malar J; 2016 Jul; 15(1):346. PubMed ID: 27388012
[TBL] [Abstract][Full Text] [Related]
26. Transcriptional expression of glioma chemotherapy drugs associated marker molecules in gliomas and normal brain tissues.
Zhao Y; Xue Y; Zhang Q; Wang K; Yin J; Lou M
Cancer Biomark; 2013; 13(1):59-66. PubMed ID: 23736022
[TBL] [Abstract][Full Text] [Related]
27. [Glucose-6-phosphate dehydrogenase deficiency in Japan].
Kanno H; Ogura H
Rinsho Ketsueki; 2015 Jul; 56(7):771-7. PubMed ID: 26251139
[TBL] [Abstract][Full Text] [Related]
28. Neonatal jaundice and molecular mutations in glucose-6-phosphate dehydrogenase deficient newborn infants.
Huang CS; Hung KL; Huang MJ; Li YC; Liu TH; Tang TK
Am J Hematol; 1996 Jan; 51(1):19-25. PubMed ID: 8571933
[TBL] [Abstract][Full Text] [Related]
29. HSPB1 Enhances SIRT2-Mediated G6PD Activation and Promotes Glioma Cell Proliferation.
Ye H; Huang H; Cao F; Chen M; Zheng X; Zhan R
PLoS One; 2016; 11(10):e0164285. PubMed ID: 27711253
[TBL] [Abstract][Full Text] [Related]
30. The "go or grow" potential of gliomas is linked to the neuropeptide processing enzyme carboxypeptidase E and mediated by metabolic stress.
Höring E; Harter PN; Seznec J; Schittenhelm J; Bühring HJ; Bhattacharyya S; von Hattingen E; Zachskorn C; Mittelbronn M; Naumann U
Acta Neuropathol; 2012 Jul; 124(1):83-97. PubMed ID: 22249620
[TBL] [Abstract][Full Text] [Related]
31. Expression of ADP-ribosyltransferase 1 Is Associated with Poor Prognosis of Glioma Patients.
Li Z; Yan X; Sun Y; Yang X
Tohoku J Exp Med; 2016 Aug; 239(4):269-78. PubMed ID: 27466078
[TBL] [Abstract][Full Text] [Related]
32. CBF1 is clinically prognostic and serves as a target to block cellular invasion and chemoresistance of EMT-like glioblastoma cells.
Maciaczyk D; Picard D; Zhao L; Koch K; Herrera-Rios D; Li G; Marquardt V; Pauck D; Hoerbelt T; Zhang W; Ouwens DM; Remke M; Jiang T; Steiger HJ; Maciaczyk J; Kahlert UD
Br J Cancer; 2017 Jun; 117(1):102-112. PubMed ID: 28571041
[TBL] [Abstract][Full Text] [Related]
33. Identification of Neural Progenitor Cell-associated Chemoradiotherapy Resistance Gene Set (
Yang Y; Xu X; Xie Y; Liu Y; Ning C; Ai Y; Lv C; Wei H; Ge X; Yi T; Piao Y; Wang X; Jin X
Curr Pharm Des; 2022; 28(26):2189-2202. PubMed ID: 35718975
[TBL] [Abstract][Full Text] [Related]
34. Genomically amplified Akt3 activates DNA repair pathway and promotes glioma progression.
Turner KM; Sun Y; Ji P; Granberg KJ; Bernard B; Hu L; Cogdell DE; Zhou X; Yli-Harja O; Nykter M; Shmulevich I; Yung WK; Fuller GN; Zhang W
Proc Natl Acad Sci U S A; 2015 Mar; 112(11):3421-6. PubMed ID: 25737557
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of glucose-6-phosphate dehydrogenase deficiency and the role of the A- variant in a Saudi population.
Alharbi KK; Khan IA
J Int Med Res; 2014 Oct; 42(5):1161-7. PubMed ID: 25169987
[TBL] [Abstract][Full Text] [Related]
36. Chronic nonspherocytic hemolytic anemia due to glucose-6-phosphate dehydrogenase deficiency: report of two families with novel mutations causing G6PD Bangkok and G6PD Bangkok Noi.
Tanphaichitr VS; Hirono A; Pung-amritt P; Treesucon A; Wanachiwanawin W
Ann Hematol; 2011 Jul; 90(7):769-75. PubMed ID: 21302115
[TBL] [Abstract][Full Text] [Related]
37. Co-inheritance of glucose-6-phosphate dehydrogenase deficiency mutations and hemoglobin E in a Kachin population in a malaria-endemic region of Southeast Asia.
Deng Z; Yang F; Bai Y; He L; Li Q; Wu Y; Luo L; Li H; Ma L; Yang Z; He Y; Cui L
PLoS One; 2017; 12(5):e0177917. PubMed ID: 28531196
[TBL] [Abstract][Full Text] [Related]
38. Glucose-6-phosphate dehydrogenase variants associated with favism in Thai children.
Laosombat V; Sattayasevana B; Chotsampancharoen T; Wongchanchailert M
Int J Hematol; 2006 Feb; 83(2):139-43. PubMed ID: 16513531
[TBL] [Abstract][Full Text] [Related]
39. Proteome-wide dysregulation by glucose-6-phosphate dehydrogenase (G6PD) reveals a novel protective role for G6PD in aflatoxin B₁-mediated cytotoxicity.
Lin HR; Wu CC; Wu YH; Hsu CW; Cheng ML; Chiu DT
J Proteome Res; 2013 Jul; 12(7):3434-48. PubMed ID: 23742107
[TBL] [Abstract][Full Text] [Related]
40. Modulation of doxorubicin resistance by the glucose-6-phosphate dehydrogenase activity.
Polimeni M; Voena C; Kopecka J; Riganti C; Pescarmona G; Bosia A; Ghigo D
Biochem J; 2011 Oct; 439(1):141-9. PubMed ID: 21679161
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
